Juan Carlos Hernández‐Boluda

ORCID: 0000-0002-4289-3113 · 3 papers in corpus · active 2000-2020

Study types

  • article 3
article 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
·doi:10.1016/j.medcle.2019.11.010
article 2015
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results
·doi:10.1007/s00277-015-2435-7
article 2000
Danazol treatment of idiopathic myelofibrosis with severe anemia.

BACKGROUND AND OBJECTIVE: Severe anemia is an important problem in patients with idiopathic myelofibrosis (IM). When other therapeutic measures are unsuccessful or not applicable, 40-50% favorable responses are obtained with androgen therap…